Anxiety and depressive disorders in tobacco dependence;Troubles anxieux et dépressifs dans la dépendance tabagique

Encephale

Volumn 28, Issue 4, 2002, Pages 374-377

  Lagrue, G ^a   Dupont, P ^a   Fakhfakh, R ^a  

^a Hopital Albert Chenevier   (France)

Author keywords

Anxiety; Depression; Nicotine; Selective serotonin reuptake inhibitors; Social phobia; Tobacco dependence

Indexed keywords

NICOTINE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR;

AFFECTIVE NEUROSIS; ANXIETY; DEPRESSION; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RELAPSE; REVIEW; SCORING SYSTEM; SOCIAL PHOBIA; SUBSTITUTION THERAPY; TOBACCO DEPENDENCE; WELLBEING;

ADULT; ANXIETY DISORDERS; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; PERSONALITY INVENTORY; PHOBIC DISORDERS; SEROTONIN UPTAKE INHIBITORS; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 0036381511     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Akiskal H. La dysthymie et son traitement. Encephale 1993; 19: 375-8.
2. Bock B, Goldstein M, Marcus B. Depression Following Smoking Cessation in Women. J Subst Abuse 1996; 82: 137-44.
3. Borelli B, Bock B, Martens B. The Impact of Depression on Smoking Cessation in Women. Am J Prev Med 1996; 12: 378-87.
4. Collet L, Cottraux J. Inventaire abrégé de dépression de Beck (13 Items). Étude de la validitė. Encephale 1986; 12: 77-9.
5. Glassman AH. Cigarette smoking: Implications for psychiatric Illness. Am J Psychiat 1993; 150: 546-53.
6. Heatherton T, Fagerström KO. The Fagerström test for nicotine dependence: a revision of the Fagerström Tolerance Questionnaire. Brit J Addiction 1991; 86: 1119-27.
7. Henning SE, Kiss JP, Vizi E. Nicotine acetylcholine receptor antagonist effect of fluoxetine in rat hippocampal slices. Brain Res 1997; 159: 292-4.
8. Hurt RD, Sachs DP et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997; 337: 1195-202.
9. Lagrue G, Lebargy F. Le tabagisme cent ans après. Presse Med 1993; 22: 1595-8.
10. Lagrue G, Lebargy F. Le dosage de la cotinine urinaire: un guide pour l'adaptation posologique du traitement de la dépendance tabagique par la nicotine. Sem Hôp Paris 1994; 70: 387-90.
11. Lagrue G. Les psychotropes dans l'aide à l'arrêt du tabac: aspects pratiques. In: Aubin HJ, ed. Nicotine et troubles psychiatriques, 1 vol. Paris: Masson 1997; 101-7.
12. Lagrue G, Cormier S, Porta A. Dépistage et traitement des états dépressifs et anxieux en tabacologie. Act Med Psychiatrie 1997; 200 (Suppl): 18-20.
13. Lerman C, Audrain J, Orleans T et al. Investigation of the mechanisms linking depressed mood to nicotine dependence. Addiction Behaviors 1996; 21: 9-19.
14. Markou A, Kosten T, Koob J. Neurobiological similarities in depression and drug dependence: a self medication hypothesis. Neuropsychopharmacol 1998; 18: 135-74.
15. Niaura R, Goldstein, Abrams D. Fluoxetine, symptoms of depression and smoking cessation. Ann Beh Med 1995; 17: S-38.
16. Olausson P, Engel J, Soderpalm B. Citoprolam attenuates the expression of behavioural sensitization to nicotine. Alcohol 1997; 32: 390.
17. Prochazka A, Weaver M, Keller et al. A randomized trial of nortriptyline for smoking cessation. Arch Int Med 1998; 158: 2935-9.
18. Salin-Pascual R, Drucker-Colin R. A novel effect of nicotine on mood and sleep in major depression. Neurol Report 1998; 9: 57-60.
19. Zigmund AS, Snaith RT. The Hospital Anxiety Depression scale. Acta Psychol Scand 1983; 67: 361-70.